Unprecedented therapeutic targeting of previously undruggable proteins has now been
achieved by molecular‐glue‐mediated proximity‐induced degradation. As a small GTPase …

Abstract Analysis of gene expression patterns in gastric cancer (GC) can help to identify a
comprehensive panel of gene biomarkers for predicting clinical outcomes and to discover …

Colchicine has been used to treat gout and, more recently, to effectively prevent
autoinflammatory diseases and both primary and recurrent episodes of pericarditis. The anti …

Background Gallbladder cancer (GBC) is a relatively uncommon carcinoma among
gastrointestinal cancers and usually has a rather poor prognosis. The most common subtype …

Several prognostic gene signatures have been developed to predict the clinical outcome in
patients with multiple myeloma (MM). The most salient disadvantage of the previous …

Abstract Background Cerebral cavernous malformations (CCMs) are vascular abnormalities
associated with deregulated angiogenesis. Their pathogenesis and optimal treatment …

2016-06-17 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

NZ754139A - Novel peptides and combination of peptides for use in immunotherapy against
ovarian cancer and other cancers - Google Patents NZ754139A - Novel peptides and …

The human eukaryotic release factor 3a (eRF3a), encoded by the G1 to S phase transition 1
gene (GSPT1; alias eRF3a), is upregulated in various human cancers. GSPT1 contains a …

The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …